Cargando…
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
BACKGROUND: Treatment adherence is one of the key factors for achieving optimal clinical outcomes. In order to assess costs related to adherence to, and persistence and compliance with, disease-modifying therapies (DMTs) in patients with multiple sclerosis (MS), a narrative review of the literature...
Autores principales: | Lizán, Luis, Comellas, Marta, Paz, Silvia, Poveda, José Luis, Meletiche, Dennis M, Polanco, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262214/ https://www.ncbi.nlm.nih.gov/pubmed/25525341 http://dx.doi.org/10.2147/PPA.S67253 |
Ejemplares similares
-
Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment
por: Garcia-Dominguez, José Manuel, et al.
Publicado: (2016) -
Use of an Early Disease-Modifying Drug Adherence Measure to Predict Future Adherence in Patients with Multiple Sclerosis
por: Kozma, Chris M., et al.
Publicado: (2014) -
Additional Value of Patient-Reported Symptom Monitoring in Cancer Care: A Systematic Review of the Literature
por: Lizán, Luís, et al.
Publicado: (2021) -
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis
por: Kozma, Chris M, et al.
Publicado: (2013) -
Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature
por: Torre-Alonso, Juan Carlos, et al.
Publicado: (2018)